Amniotic Membrane Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Amniotic Membrane Market is segmented by Enzyme (Cryopreserved Amniotic Membrane and Dehydrated Amniotic Membrane), Application (Ophthalmology, Surgical Wounds, and Other Applications), End User (Hospitals, Ambulatory Surgical Centers, and Other End Users), and Geography.

Market Snapshot

amniotic membrane market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 10.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The amniotic membrane market is expected to register a CAGR of 10.5% during the forecast period. This can be attributed to the rise in the number of accident and trauma cases and increasing awareness about the benefits offered by the amniotic membrane.

  • Amniotic membrane has several antimicrobial and biological properties in corneal surgery, as it enhances epithelialization, reinforces adhesion of basal epithelial cells, maintains epithelial phenotype, and modulates the proliferation of normal corneal, conjunctival, and limbal fibroblast. These membranes also prevent apoptosis, as well as inhibit scarring, inflammation, and neovascularization.
  • The advantages of amniotic membranes, like its pain-reducing properties, may lead to the rising adoption of these tissue-based products in ophthalmology and surgical wounds. Moreover, the growing number of surgeries performed and rising expenditure in R&D in the field of stem cells and regenerative medicine are also some of the key factors driving the overall market.
  • As per the Global Burden of Diseases, in 2017, an estimate of 8,99,10,460.00 cases of burn injuries was registered globally. Driven by this high incidence of burn injuries, the inflammatory and anti-scarring properties of the amniotic membrane are pivotal in reducing intensified inflammation and discomfort and, thus, boost the overall market.

Scope of the Report

The amniotic membrane consists of a combination of tissues and cells, and it is the innermost layer of the placenta, which is widely used in ophthalmology and wound healing. The amniotic membrane market is segmented by enzyme, application, end user, and geography.

By Enzyme
Cryopreserved Amniotic Membrane
Dehydrated Amniotic Membrane
By Application
Ophthalmology
Surgical Wounds
Other Applications
By End User
Hospitals
Ambulatory Surgical Centers
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

The Opthalmology Segment is Estimated to Witness a Healthy Growth in the Future.

The ophthalmology segment is estimated to witness a healthy growth in the future, which can be majorly attributed to the widespread use of these tissue-based products in ophthalmic surgeries due to their fast recovery properties, like reducing inflammation and promoting healing. The increasing use of the amniotic membrane in ophthalmic plastic and reconstructive surgeries to reduce scarring and diagnose quickly is propelling the segment growth. Moreover, the rising number of patients opting for surgeries, for the aesthetic appeal, is also boosting the amniotic membrane market. For instance, as per the American Society of Plastic Surgeons, in 2018, 17.7 million cosmetic procedures were carried out. The increasing demand for products in cosmetic surgeries and reconstructive surgeries is driving the overall market. Compared to xenografts and allografts, amniotic membranes are cheaper, which also promotes the segment growth.

In addition, the growing population of glaucoma patients globally fuels the amniotic membrane market, as these tissue-based products are used for the treatment for ocular surface diseases and in glaucoma for the repair of leaking glaucoma filtering blebs.

key trends amniotic.png

North America is Expected to Hold a Significant Share in the Market during the Forecast Period

North America is expected to hold a significant market share due to the increasing aging population, adoption of advanced technologies, growing awareness among the population about alternatives technologies, increasing healthcare expenditure, and the presence of well-established healthcare infrastructure. The wide use of amniotic membranes is for eye surface disorders, leading to the adoption of these products in ophthalmic surgeries. Thus, the increasing number of ophthalmic surgeries performed in the United States, due to the geriatric population, is fueling the growth of the overall market to a large extent.

geography amniotic.png

Competitive Landscape

The amniotic membrane market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies currently dominating the market include Amnio Technology LLC, Celularity Inc., Human Regenerative Technologies LLC, Katena Products Inc., MiMedx, Integra LifeSciences Corporation, Skye Biologics Inc., and Amniox Medical Inc.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rise in the Number of Accident and Trauma Cases

      2. 4.2.2 Increasing Awareness about the Benefits Offered by Amniotic Membrane

      3. 4.2.3 Rising Research on Stem Cell Biology and Regenerative Medicine

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Standardized Guidelines

      2. 4.3.2 Lack of Skilled Professionals

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Enzyme

      1. 5.1.1 Cryopreserved Amniotic Membrane

      2. 5.1.2 Dehydrated Amniotic Membrane

    2. 5.2 By Application

      1. 5.2.1 Ophthalmology

      2. 5.2.2 Surgical Wounds

      3. 5.2.3 Other Applications

    3. 5.3 By End User

      1. 5.3.1 Hospitals

      2. 5.3.2 Ambulatory Surgical Centers

      3. 5.3.3 Other End Users

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Amnio Technology LLC

      2. 6.1.2 Celularity Inc.

      3. 6.1.3 Human Regenerative Technologies LLC

      4. 6.1.4 Katena Products Inc.

      5. 6.1.5 MiMedx

      6. 6.1.6 Integra LifeSciences Corporation

      7. 6.1.7 Skye Biologics Inc.

      8. 6.1.8 Amniox Medical Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Amniotic Membrane Market market is studied from 2018 - 2026.

The Amniotic Membrane Market is growing at a CAGR of 10.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Amnio Technology, LLC, Celularity, Inc., Human Regenerative Technologies, LLC, Katena Products. Inc., MiMedx are the major companies operating in Amniotic Membrane Market .

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!